Infectious disease update: new anti-microbials.
Effective antimicrobials are critical in controlling one of the most common conditions encountered in medicine, namely, skin and skin structure infections. Unfortunately, the identification of appropriate and novel antimicrobials is continually challenged by the emergence of antimicrobial resistance among bacteria, fungi, and parasites. This work will focus on describing novel antibacterials and antifungals approved by the United States Food and Drug Administration in the past 4 years.
Yang
Aparche
A
Dermatology Resident, Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, Miami, FL 33136, USA.
Kerdel
Francisco A
FA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D006801:Humans; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents